Plans for a massive new 44-storey residential skyscraper in the heart of Manchester city centre havetaken another big step forward.
But does it mean change to one of Manchester‘s most famous views?
Located on what has been referred to as a “prominent site” adjacent to Deansgate train station and Deansgate-Castlefield tram stop at Whitworth Street West, the dramatic proposals would see the development of a total of 364 apartments set over 44 storeys.
Developers Glenbrook say the building has been designed to “respond to the city’s heritage”, most notably through its three-storey arched terracotta colonnade at street level.
Well-lit new green spaces, enhancements to existing pedestrian routes and seamless integration with the surrounding communities, all form part of the landscaping proposals for the bold new project.
ADVERTISEMENT
“As a Manchester-based developer, we are excited about the prospect of embarking on a landmark development in the heart of our city”, says Daniel Roberts, the Development Director at Glenbrook.
“Whitworth Street West is undergoing a period of revitalisation, and Glenbrook is incredibly proud to be playing such an integral part in its future.”
ADVERTISEMENT
Following a public consultation back in October, a planning permission application has been officially submitted to Manchester City Council (MCC).
However, should plans move ahead, it would involve the demolition of the two existing buildings – Wrendal House and Whitworth House – before work can commence.
The project’s start date at present is pencilled in for early 2026.
ADVERTISEMENT
A CGI of a proposed skyscraper on Whitworth Street West in Manchester. (Credit: Glenbrook)
As mentioned, local residents, businesses and interested stakeholders were invited to view the plans in detail and provide their thoughts on the proposals as they stand.
The development will cover a range of one, two and three-bed flats distributed across the tower’s upper 41 floors (120 one-beds, 218 two-beds and 26 three-bed homes).
There is also approximately 7,800 sq ft of active space on the ground, first, and second-floor levels which could be used for a variety of amenities, business and leisure purposes.
One thing to note so far is that no car parking is currently included in the blueprints, as the developers and property managers are set to encourage residents to walk and/or use the city’s various and newly-invigorated public transport links under the Bee Network.
The view of what Whitworth Street West currently looks like in October 2024. (Credit: The Manc Group)
According to developers, the feedback gathered during the consultation will play a key role in shaping the final planning application how work can ultimately ensure the development meets the needs of the community will also be taken into account.
ADVERTISEMENT
Standard planning permission applications obviously vary on a case-to-case basis but a decision is usually reached within 8-13 weeks.
The scheme can be found on the MCC’s planning portal, using the reference number: 141773/FO/2024.
Yet another major Deansgate Locks nightlife spot has closed in Manchester
Daisy Jackson
Deansgate Locks is set to lose yet another of its nightlife spots, with Ark confirming it will be shutting its doors ‘within weeks’.
The multi-room, multi-storey, multi-genre nightclub has been part of the canalside development for more than a decade, having first opened back in 2014.
At that time, Deansgate Locks was arguably Manchester’s leading nightlife destination, drawing hundreds of students and party-goers to its mix of venues.
The railway arches have been home to iconic clubs and bars including Baa Bar, Lola Lo, Revolution, and Sugar Buddha, as well as The Comedy Store.
But with news that Ark Manchester is closing too, it leaves only Popworld left at what was previously one of the city’s hottest destinations.
In a statement shared with the Manchester Evening News, a spokesperson for Stonegate said: “The hospitality sector continues to face significant challenges.
Ark Manchester will be closing for goodIt leaves Deansgate Locks with just one venue
“After careful consideration, and despite our best efforts, Ark Manchester is no longer commercially viable and we have taken the difficult decision to close the venue.
“Our priority is to support our hard‑working team during this time, and we would like to thank them for their commitment and dedication. We would also like to thank our guests and the local community for their support over the years.”
It’s believed that Ark Manchester will close on Deansgate Locks in the next few weeks.
Groundbreaking endometriosis tests could help catch diagnosis ‘years earlier’
Danny Jones
In some major public health news, two pioneering and crucially faster tests for endometriosis, which are set to be rolled out across Great Britain soon, could be about to reduce the time taken to diagnose the condition by several years.
That’s according to the National Institute for Healthand Care Excellence (NICE), who have issued an update revealing that the fresh testing technology could significantly speed up the process that can currently take the best part of a decade or even more.
In some cases, it can take upwards of 11 years to fully identify endometriosis, especially within certain ethnically diverse communities, but now the executive non-departmental public body has given the green light for the NHS to introduce the pair of expeditious testing methods here in the UK.
Announced on Tuesday, 7 July, the dual approach – one half of which is already being used domestically as part of a pilot study – won’t serve as a standalone diagnostic system in itself, but should help drastically reduce the time between suspected symptoms, confirmation and treatment.
In the UK, average diagnosis takes over 9 years.
Endosure and Endotest can now be used in the NHS while more evidence is gathered.
Emma Cox, chief executive of Endometriosis UK, said in a public statement: “Availability of these new tests needs to go hand-in-hand with education of GPs and practice nurses to ensure prompt access to those that need them, and an end to pain and symptoms not being recognised.”
The two prongs of this new approach revolve around the already in-trialEndotest®, currently being manufactured by French biotech company Ziwig.
Essentially a straightforward saliva test, it’s been recommended for wider use over some time now.
Meanwhile, the second step is ‘EndoSure’: a non-invasive test that uses “topical electrode pads similar to those used in an electrocardiogram (ECG) to measure the myoelectric activity of the smooth muscle of the GI tract”, with sensors placed on the stomach area.
You can see an instructional video explaining more information about the former down below.
Put in the simplest terms, in tandem, they could save one in 10 women lots of time and pain.
Dr Anastasia Chalkidou, healthtech programme director at NICE, went on to add: “A diagnosis of endometriosis can for some women take the best part of a decade […] That delay means living with chronic pelvic pain that affects daily life, relationships and work.
“These technologies have the potential to change that by giving primary care professionals better non-invasive tools to identify endometriosis earlier, allowing earlier and better treatment.
“Our draft guidance reflects our commitment to getting promising innovations to patients quickly, while making sure the evidence to support their wider use is built in a rigorous way.”
While both are still pending full approval and eventual scaling across the country, here’s hoping it can make the difference in the lives of millions of British women and beyond.
Emily Sergeant -
10th October 2024 
